An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection

Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplif...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun, Yan, Zhang, Kaixi, Santos, May Delos, Pee, Carmen J. E., Yang, Yanmeng, Kang, Meiqi, Shin, Sung Jae, Chan-Park, Mary B., Pethe, Kevin
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2024
Subjects:
Online Access:https://hdl.handle.net/10356/180529
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-180529
record_format dspace
spelling sg-ntu-dr.10356-1805292024-10-13T15:37:47Z An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection Sun, Yan Zhang, Kaixi Santos, May Delos Pee, Carmen J. E. Yang, Yanmeng Kang, Meiqi Shin, Sung Jae Chan-Park, Mary B. Pethe, Kevin Lee Kong Chian School of Medicine (LKCMedicine) School of Chemistry, Chemical Engineering and Biotechnology Interdisciplinary Graduate School (IGS) Singapore-MIT Alliance for Research and Technology Centre National Centre for Infectious Diseases, Singapore Centre for Antimicrobial Bioengineering Singapore Centre for Environmental Life Sciences and Engineering (SCELSE) Medicine, Health and Life Sciences Mouse model Lung infection Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplified immunosuppressed mouse model using only four injections of cyclophosphamide, which allows for sustained M. abscessus lung burden for up to 16 days. This model proved effective for antibiotic efficacy evaluation, as demonstrated with imipenem or amikacin. Ministry of Education (MOE) National Research Foundation (NRF) Published version This research was supported in part by the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 3 (Grant MOE2018- T3-1-003), by a MOE Tier 1 (Grant RT01/20), by the National Research Foundation (NRF) Singapore under its Investigatorship Program (grant NRF-NRFI06-2020-0004), and under its Campus for Research Excellence and Technological Enterprise (CREATE) programme through the SMART AMR IRG. 2024-10-10T02:54:27Z 2024-10-10T02:54:27Z 2024 Journal Article Sun, Y., Zhang, K., Santos, M. D., Pee, C. J. E., Yang, Y., Kang, M., Shin, S. J., Chan-Park, M. B. & Pethe, K. (2024). An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection. Antimicrobial Agents and Chemotherapy, 68(8). https://dx.doi.org/10.1128/aac.01520-23 0066-4804 https://hdl.handle.net/10356/180529 10.1128/aac.01520-23 68 2-s2.0-85200938507 8 68 en MOE2018-T3-1-003 RT01/20 NRF-NRFI06-2020-0004 Antimicrobial Agents and Chemotherapy © 2024 American Society for Microbiology. All rights reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1128/aac.01520-23 application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Medicine, Health and Life Sciences
Mouse model
Lung infection
spellingShingle Medicine, Health and Life Sciences
Mouse model
Lung infection
Sun, Yan
Zhang, Kaixi
Santos, May Delos
Pee, Carmen J. E.
Yang, Yanmeng
Kang, Meiqi
Shin, Sung Jae
Chan-Park, Mary B.
Pethe, Kevin
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
description Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplified immunosuppressed mouse model using only four injections of cyclophosphamide, which allows for sustained M. abscessus lung burden for up to 16 days. This model proved effective for antibiotic efficacy evaluation, as demonstrated with imipenem or amikacin.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Sun, Yan
Zhang, Kaixi
Santos, May Delos
Pee, Carmen J. E.
Yang, Yanmeng
Kang, Meiqi
Shin, Sung Jae
Chan-Park, Mary B.
Pethe, Kevin
format Article
author Sun, Yan
Zhang, Kaixi
Santos, May Delos
Pee, Carmen J. E.
Yang, Yanmeng
Kang, Meiqi
Shin, Sung Jae
Chan-Park, Mary B.
Pethe, Kevin
author_sort Sun, Yan
title An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
title_short An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
title_full An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
title_fullStr An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
title_full_unstemmed An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
title_sort optimized cyclophosphamide-treated mouse model of mycobacterium abscessus pulmonary infection
publishDate 2024
url https://hdl.handle.net/10356/180529
_version_ 1814777704582479872